XML 63 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Collaborative Research, Development and License Agreements - Additional Information (Detail)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 29, 2020
USD ($)
Feb. 28, 2019
USD ($)
Feb. 28, 2018
USD ($)
Installment
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Revenue recognized       $ 2,668 $ 8,301 $ 13,587 $ 14,074  
Intangible assets, net               $ 2,500
Serum Institute of India Pvt. Ltd. | Collaboration Revenue                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Revenue recognized       $ 300 $ 0 $ 700 $ 100  
Merck, Sharp & Dohme Corp. | Sublicense Agreement                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Aggregate amount payable to acquire intangible assets     $ 21,000          
Number of installments | Installment     3          
Payment upon obligation $ 7,000 $ 7,000 $ 7,000          
Agreement expiration month and year     2020-04          
Intangible assets, net               $ 2,500